Juno Therapeutics (JUNO) – Reuters
-
Drugmaker Shire soars as Japan's Takeda considers bid
-
Stocks hit record as senators reach deal to end shutdown
-
FDA panel backs Novartis' pioneering new cancer gene therapy
-
Dow, S&P 500 set record high closes ahead of holiday
Back to JUNO Stock Lookup